Considering the different tumor stages, the median CMG2 mRNA expression in stage 2 and 3 tumors (0.017 and 0.016 fg/fg HPRT, respectively) was slightly, but also not significantly, lower than in stage 1 or stage 4 tumors (0.025 and 0.026 fg/fg HPRT, respectively, see Figure 1b). Here, ANTXR2 is linked to neoplasm.